Why Longevity Medicine Is Shifting From Optimization to Disease Interception | Dr. Julie Chen, MD - Chief Medical Officer - Radence and Sidestep Health AI

Send us Fan MailWhat if the future of medicine isn’t about treating disease…but detecting it 20 years before symptoms ever appear? Dr. Julie Chen, MD is helping lead one of the newest precision-health companies trying to build that future.Dr. Julie Chen, MD is a physician operating at one of the most interesting intersections in modern medicine: rigorous clinical research, precision longevity medicine, integrative care, and the rapidly evolving world of AI-driven health optimization.Dr. Chen graduated Summa Cum Laude and Phi Beta Kappa from the University of Rochester before earning her M.D. with Distinction in Research and Alpha Omega Alpha honors from the university’s School of Medicine. She went on to complete her internal medicine residency and later trained in integrative medicine under Andrew Weil at the University of Arizona Center for Integrative Medicine.Over the course of her career, Dr. Chen has conducted research and published work through institutions including the U.S. Food and Drug Administration, National Institutes of Health, National Cancer Institute, Mount Sinai School of Medicine, and University of Southern California.Dr. Chen has also become a prominent operational leader in the longevity industry, serving in executive medical roles at companies including Human Longevity, Inc., Vitagene, and now as Chief Medical Officer of Radence ( https://radence.com/ ) and Sidestep Health AI. She additionally serves as a Leadership Circle Advisor for the Buck Institute for Research on Aging.What makes Dr. Chen particularly compelling is that she has seen the longevity ecosystem from nearly every angle: academic medicine, FDA-level research, integrative clinical care, Silicon Valley health-tech, and AI-enabled prevention.In today’s conversation, we’ll explore where the science around longevity is genuinely promising, where the hype may be outrunning the evidence, how precision medicine is shifting toward early disease interception, and what responsible longevity medicine should actually look like in an era increasingly driven by consumer demand and social-media-driven health trends.#Longevity #Peptides #PrecisionMedicine #Healthspan #DrJulieChen #PreventiveMedicine #Biohacking #Aging #DiseaseInterception #GLP1 #LongevityMedicine #AIHealthcare #IntegrativeMedicine #HealthOptimization #HumanLongevity #FutureOfMedicine #MetabolicHealth #PreventiveHealth #Biotech #CraigVenter #Wearables #Biomarkers #Genomics #RadenceSupport the show